CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder

Brain Research

Volumn 1095, Issue 1, 2006, Pages 154-158

  Hou, Cailan ^a   Jia, Fujun ^b   Liu, Yi ^c   Li, Lingjiang ^a  

^a Central South University   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c First Affiliated Hospital   (China)

Author keywords

5 hydroxyindolacetic acid; Cerebrospinal fluid; Major depressive disorder; Neuropeptide Y; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BIOLOGICAL MARKER; NEUROPEPTIDE Y; SEROTONIN;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG CEREBROSPINAL FLUID LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; NEUROPEPTIDE Y; SEROTONIN; SPINAL PUNCTURE;

EID: 33744988989     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.026     Document Type: Article

References (27)

1. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 4th ed. (2000), American Psychiatric Press, Washington, DC (text revision)
2. Arato M., Tekes K., Tothfalusa L., Magyar K., Palkovits M., Frecska E., and Falus A. Biol. Psychiatry 29 (1991) 699-702
3. Asberg M., Thoren P., Traskman L., Bertilsson L., and Ringberger V. Serotonin depression: a biological subgroup within the affective disorder?. Science 191 (1976) 478-480
4. Berrettini W.H., Duran A.R., Kelwe J., Roy A., and Pickar D. Cerebrospinal fluid neuropeptideY in depression and schizophrenia. Neuropsychopharmacology 1 (1987) 81-83
5. Changming Z., Kejun H., Huikai Z., Bingshuang H., and Huaqi Y. The assessment of severity of depression symptoms. Chin. J. Nerv. Ment. Dis. 18 (1985) 295-297
6. Cooper S.J., Kelly C.B., and King D.J. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340 (1992) 940-941
7. Gjerris A., Widerlov E., Werdelin L., and Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J. Psychiatry Neurosci. 17 (1992) 23-27
8. Gottfries G., Gottfries L., Johansson B., Olsson R., Persson T., Roos B., and Sjostrom R. Neuropharmacology 210 (1971) 665-672
9. Guoxian L., and Changming Z. The use of HAMA in neurosis. Chin. J. Nerv. Ment. Dis. 19 (1986) 342-344
10. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
11. Heilig M., and Widerlov E. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr. Scand. 82 (1990) 95-114
12. Heilig M., Wahlestedt C., Ekman R., and Widerlov E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmacol. 147 (1988) 465-467
13. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjogren M., Asverg M., Ekmann R., Wahlestedt C., and Agren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J. Psychiatr. Res. 38 (2004) 113-121
14. Heninger A. Serotonin, sex, and psychiatric illness. Proc. Natl. Acad. Sci. 94 (1997) 4823-4824
15. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev., Neurosci. 4 (2003) 819-827
16. Mann J.J., McBride P.A., Malone K.M., DeMeo M.D., and Kelip J.G. Blunted serotonergic responsivity in depressed patients. Neuropsychopharmacology 13 (1995) 53-64
17. Mann J.J., Malone K.M., Psych M.R., Sweeney J.A., Brown R.P., Linnoila M., Stanley B., and Stanley M. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15 (1996) 576-586
18. Marie L.S., Luquet S., Cole T.B., and Palmiter R.D. Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc. Natl. Acad. Sci. 102 (2005) 18632-18637
19. Molcho A., Stanley B., and Stanley M. Biological studies and markers in suicide and attempted suicide. Int. Clin. Psychopharmacol. 6 (1991) 77-92
20. Moore K.A., Werner C., Zannelli R.M., Levine B., and Smith M.L. Screening postmortem blood and tissues for nine cases of drugs of abuse using automated microplate immunoassay. Forensic Sci. Int. 106 (1999) 93-102
21. Ordway G.A., Stockmeier C.A., Meltzer H.Y., Overholser J.C., Jaconetta S., and Widdowson P.S. Neuropeptide Y in frontal cortex is not altered in major depression. J. Neurochem. 65 (1995) 1646-1650
22. Redrobe J.P., Dumont Y., and Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Lif Sci. 71 (2002) 2921-2937
23. Roy A. Neuropeptides in relation to suicidal behavior in depression. Neuropsychobiology 28 (1993) 184-186
24. Traskman-Bendz L., Asberg M., Bertilsson L., and Thoren P. CSF monoamine metabolites of depressed patients during illness and recovery. Acta Psychiatr. Scand. 69 (1984) 333-342
25. Traskman-Bendz L., Ekman R., Regne'll G., and Ohman R. HPArelated CSF neuropeptides in suicide attempters. Eur. Neuropsychopharmacol. 2 (1992) 99-106
26. Weissman M.M., and Olfson M. Depression in women: implication for health care research. Science 269 (1995) 799-801
27. Widdowson P.S., Ordway G.A., and Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J. Neurochem. 59 (1992) 73-80